Somatic GATA2 mutations define a subgroup of myeloid malignancy patients at high risk for invasive fungal disease

Rahul S. Vedula, Matthew P. Cheng, Christine E. Ronayne, Dimitrios Farmakiotis, Vincent T. Ho, Sophia Koo, Francisco M. Marty, R. Coleman Lindsley, Tyler D. Bold

Research output: Contribution to journalArticlepeer-review

11 Scopus citations

Fingerprint

Dive into the research topics of 'Somatic GATA2 mutations define a subgroup of myeloid malignancy patients at high risk for invasive fungal disease'. Together they form a unique fingerprint.

Medicine and Dentistry

Immunology and Microbiology